Rasha M. El Refai

Rasha M. El Refai

Auto-generated profile, based on publicly available information

Rasha M. El Refai

Texas Children's Hospital

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2018 in Laboratory Medicine
Verified
Journal Article
Closed access
DLDalia A Labib
Dalia A Labib
OSOlfat Shaker
Olfat Shaker
RRRasha M El Refai
Rasha M El Refai
SGShada A Ghoniem
Shada A Ghoniem
AEAlaa Elmazny
Alaa Elmazny
Single-nucleotide polymorphisms (SNPs) in microRNA-146a (miRNA-146a) can be associated with the development of immune-system dysfunctions.The aim of this work is to correlate SNPs of miRNA-146a and its target gene, IRAK1, with susceptibility, clinical manifestations, and diseases progression in patients with systemic lupus erythematous (SLE) and multiple sclerosis (MS). Genotyping for miRNA-146a (rs2910164) and its target gene IRAK1 (rs3027898) was performed using real-time polymerase chain reaction (RT-PCR) in 80 patients with SLE and 70 patients with MS, as well as 120 healthy control individuals. A statistically significant difference was found between the frequencies of the genotypes and alleles of miRNA-146a (rs2910164) and IRAK1 (rs3027898), compared with the control group. Also, whereas the mutant allele G of miRNA-146a may be a factor in the pathogenesis of lupus nephritis, the mutant allele C of IRAK1 may play a role in lupus arthritis. Both genes may contribute to the susceptibility of patients to SLE and MS.

1 October 2015 in The Egyptian Rheumatologist
Verified
Journal Article
Open access
SMSiham Aly Metawie
Siham Aly Metawie
RERasha M. ElRefai
Rasha M. ElRefai
SESuzan Sadek ElAdle
Suzan Sadek ElAdle
RSRasha Mohamad Hosny Shahin
Rasha Mohamad Hosny Shahin
Aim of the workThe aim of our study was to assess the serum levels of transforming growth factor-β1 (TGF-β1) in Egyptian systemic lupus erythematosus (SLE) patients in order to determine whether these levels are associated with disease activity and organ damage.Patients and methodsSerum level of TGF-β1 was assessed in 70 Egyptian SLE patients and 60 healthy subjects using ELISA. The levels were related to clinical features, disease activity as assessed by the SLE disease activity index (SLEDAI) and damage assessed by the Systemic Lupus International Collaborating Clinics (SLICC) index.ResultsSerum levels of TGF-β1 were significantly reduced in patients with SLE compared to levels in healthy controls (875.8±292.2pg/ml vs 1140±301pg/ml, respectively) (p10) while the level tended to be lower in those with organ damage. TGF-β1 was significantly lower in patients with serum creatinine >1.2mg/dl than in those with 50ml/min (p=0.038).ConclusionThis study demonstrated significantly reduced serum levels of TGF-β1 in patients with SLE compared with healthy subjects. Lower serum TGF-β1 levels were associated with high disease activity and organ damage in SLE patients. A prominent role in renal damage was observed

1 October 2018 in The Egyptian Rheumatologist
Verified
Journal Article
Open access
ASAmira A. Shahin
Amira A. Shahin
HZHania S. Zayed
Hania S. Zayed
RERasha M. Elrefai
Rasha M. Elrefai
HTHeba Taher
Heba Taher
AEAhmed Elsaie
Ahmed Elsaie
MEMervat I. Abd Elazeem
Mervat I. Abd Elazeem

6 July 2018 in Reumatismo
Verified
Journal Article
Open access
PDF file
YEYasser Emad
Yasser Emad
TGTamer A Gheita
Tamer A Gheita
HDH. Darweesh
H. Darweesh
Peter ten KloosterPeter ten Klooster
Peter ten Klooster
RGR. Gamal
R. Gamal
JRJ. Rasker
J. Rasker
The aim was to explore possible correlations of antibodies to extractable nuclear antigens (ENA) with clinical manifestations and disease activity indices in systemic lupus erythematosus (SLE) patients. A total of 70 consecutive SLE patients (64 females) were included. Disease activity was assessed by SLE activity index (SLEDAI), and British Isles Lupus Assessment Group (BILAG). Anti-Ro/SSA correlated positively with, headache (r=0.24, p=0.04), blurring of vision (r=0.25, p=0.03) and SLEDAI (r=0.25, p=0.04) and negatively with C3 (r=–0.35, p=0.003). Anti-Ro/SSA correlated with anti La/SSB antibodies (r=0.69, p<0.001), but not with anti-DNA, anti-RNP and anti-Sm antibodies. Anti-La/SSB antibodies correlated with headache (r=0.26, p=0.03), SLEDAI (r=0.25, p=0.03) and negatively with C3 (r=–0.34, p=0.004). Anti-La/SSB did not correlate with anti-RNP or anti-Sm antibodies. Anti-Sm antibodies correlated with disease duration (r=0.34, p=0.003), 24 hours urinary proteins (r=0.31, p=0.008), SLEDAI (r=0.31, p=0.009), BILAG renal score (r=0.29, p=0.02) and negatively with age at onset (r=–0.27, p=0.02), WBCs (r=–0.29, p=0.014) and C4 (r=–0.25, p=0.049). In multivariate analyses, anti-Ro/SSA antibodies remained associated with headache, blurring of vision and C3 and anti-La/SSB antibodies remained associated with C3 and with headache. Anti-Sm antibodies were independently associated with disease duration and total SLEDAI scores, while anti-RNP antibodies remained significantly associated with BILAG mucocutaneous scores only. Antibodies to ENAs are associated with clinical aspects of SLE and may play a role in the assessment of disease activity. Insight into these ENAs may lead to new approaches to diagnostic testing, accurate evaluation of disease activity and lead to target approach for SLE.

4 April 2016 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SMSafa Meshaal
Safa Meshaal
RRRasha El Refai
Rasha El Refai
ASAhmed El Saie
Ahmed El Saie
RHRabab El Hawary
Rabab El Hawary

16 September 2015 in Reumatismo
Verified
Journal Article
Open access
PDF file
YRY. Ragab
Y. Ragab
MNM. Nabih
M. Nabih
IAI. Aly
I. Aly
AKA. Kamal
A. Kamal
MAM. A. Abd-Allah
M. A. Abd-Allah
Johannes J RaskerJohannes J Rasker
Johannes J Rasker
Hip disorders in a pediatric population are a diagnostic challenge. The aim of the study is to assess the role of magnetic resonance imaging (MRI) in the evaluation of non-traumatic hip disorders in a series of Egyptian patients and to review the literature on the most common hip conditions. Seventy two consecutive patients [40 males (55.6%) and 32 females (44.4)] with acute onset of hip complaints unrelated to trauma or falls were recruited. All patients underwent an initial full clinical assessment and blood tests as well as contrast enhanced MRI of both hips. The most common diagnosis in this group of Egyptian patients was transient synovitis in 29 (40.3%) cases, followed by seronegative enthesopathy and arthropathy syndrome in 8 (11.1%), septic arthritis in 10 (13.9%), tuberculous arthritis in 4 (5.6%), sickle-cell disease in 7 (9.7%), complicated with septic arthritis in 3 (4.2%), transient bone marrow edema (BME) in 3 (4.2%), osteomyelitis in 2 (2.8%), osteosarcoma in 2 (2.8%), sciatic nerve injury in 1 (1.4%), leukemia with BME in 1 (1.4%), coxa vara of both hips and L5/S1 facet joint ankylosis in 1 (1.4%), and a benign bone cyst in 1 (1.4%). MRI studies showed hip effusion in a total of 51 patients (70.8%), joint space narrowing in 9 (12.5%), and BME in 15(20.8%). MRI is a sensitive tool for assessing hip disorders in a pediatric population and can play an important role in both diagnosis and management of different hip disorders, irrespective of the underlying pathology.